Skip to main content

Table 1 Baseline demographics

From: Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain

 

Patient 1

Patient 2

Patient 3

Patient 4

Patient 5

Patient 6

Patient 7

Patient 8

Diagnosis

MCI

MCI

MCI

MCI

MCI

AD

AD

PSP

Age (years)

71

78

68

59

72

63

55

68

Gender

Female

Male

Female

Female

Male

Male

Female

Male

MMSE

30

29

30

29

29

15

16

29

MoCA

21

24

27

28

24

6

2

23

Global 18F-AZD4694 SUVR

2.19

1.89

1.73

0.96

0.94

2.64

2.24

1.04

  1. AD Alzheimer’s disease, MCI mild cognitive impairment, MMSE Mini-Mental State Examination, MoCA Montreal Cognitive Assessment, PSP progressive supranuclear palsy, SUVR standardized uptake value ratio
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193